BackgroundEven after curative resection, pancreatic ductal adenocarcinoma (PDAC) patients suffer a high rate of recurrence. There is an unmet need to predict which patients will experience early recurrence after resection in order to adjust treatment strategies.MethodsData of patients with resectable PDAC undergoing surgical resection between January 2005 and September 2018 were reviewed to stratify for early recurrence defined as occurring within 6 months of resection. Preoperative data including demographics, tumor markers, blood immune-inflammatory factors and clinicopathological data were examined. We employed Elastic Net, a sparse modeling method, to construct models predicting early recurrence using these multiple preoperative factors...
Background/purposeAmpullary cancer is one of the periampullary cancers with a better prognosis, but ...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selec...
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma c...
Background: This study aimed to identify predictors for early and very early disease recurrence in p...
OBJECTIVES: To establish an evidence-based cut-off to differentiate between early and late recurrenc...
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma c...
BackgroundPancreatic ductal adenocarcinoma (PDAC) often recurs early after radical resection, and su...
Surgical resection remains the only curative treatment strategy for Pancreatic Ductal Adenocarcinoma...
Abstract Background The first-...
Pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) is one of the most lethal tumour types wo...
Background: Identifying patients at risk for early recurrence (ER) following resection for pancreati...
BackgroundPatients with early-stage pancreatic neuroendocrine tumors (PNETs) may develop metastatic ...
Ampullary cancer is one of the periampullary cancers with a better prognosis, but relapse still occu...
Abstract Background Surgical resection is the only potentially curative treatment for pancreatic duc...
Importance: The patterns of disease recurrence after resection of pancreatic ductal adenocarcinoma w...
Background/purposeAmpullary cancer is one of the periampullary cancers with a better prognosis, but ...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selec...
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma c...
Background: This study aimed to identify predictors for early and very early disease recurrence in p...
OBJECTIVES: To establish an evidence-based cut-off to differentiate between early and late recurrenc...
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma c...
BackgroundPancreatic ductal adenocarcinoma (PDAC) often recurs early after radical resection, and su...
Surgical resection remains the only curative treatment strategy for Pancreatic Ductal Adenocarcinoma...
Abstract Background The first-...
Pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) is one of the most lethal tumour types wo...
Background: Identifying patients at risk for early recurrence (ER) following resection for pancreati...
BackgroundPatients with early-stage pancreatic neuroendocrine tumors (PNETs) may develop metastatic ...
Ampullary cancer is one of the periampullary cancers with a better prognosis, but relapse still occu...
Abstract Background Surgical resection is the only potentially curative treatment for pancreatic duc...
Importance: The patterns of disease recurrence after resection of pancreatic ductal adenocarcinoma w...
Background/purposeAmpullary cancer is one of the periampullary cancers with a better prognosis, but ...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selec...
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma c...